Stock TYP TRYPTAMINE THERAPEUTICS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Tryptamine Therapeutics Limited

Equities

TYP

AU0000331993

Delayed Australian S.E.
Other stock markets
 11:59:00 2024-07-15 pm EDT 		5-day change 1st Jan Change
0.023 AUD +15.00% Intraday chart for Tryptamine Therapeutics Limited +24.32% 0.00%
Jul. 10 Tryptamine Therapeutics Concludes Phase 2a Clinical Study for Pain and Tenderness Drug; Shares Rise 11% MT
Jul. 01 Tryptamine Therapeutics Doses First Patient in Intravenous Psilocin Volunteer Study MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Tryptamine Therapeutics Concludes Phase 2a Clinical Study for Pain and Tenderness Drug; Shares Rise 11%
MT
Tryptamine Therapeutics Doses First Patient in Intravenous Psilocin Volunteer Study
MT
Tryptamine Therapeutics Partners with Lucid Health to Advance TRP-8803's Product Registration in Australia
MT
Tryptamine Therapeutics Begins to Trade on ASX; Shares Surge 118%
MT
Tryp Therapeutics Files Amended Financial Statements for the Six Months Ended February 29, 2024
NE
Tryptamine Therapeutics Limited Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024
CI
3,043,860 Common Shares of Tryptamine Therapeutics Limited are subject to a Lock-Up Agreement Ending on 18-DEC-2023.
CI
3,043,860 Common Shares of Tryptamine Therapeutics Limited are subject to a Lock-Up Agreement Ending on 20-JUN-2023.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TYP Stock
  4. News Tryptamine Therapeutics Limited